Clinical trial
Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent…
NCT00020761 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00020761 |
|---|---|
| Title | Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach |
| Official title | A Phase II Study Of Irinotecan (Camptosar) And Paclitaxel (Taxol) In Patients With Adenocarcinoma Of The Upper Gastrointestinal Tract |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer, Gastric Cancer |
| Intervention type | Drug |
| Interventions | irinotecan hydrochloride, paclitaxel |
| Enrollment | 51 |
| Start date | Apr 1, 2000 |
| Primary completion | Dec 1, 2002 |
| Completion | Aug 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 3, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: